Development and investigation of recombinant immunotoxin protein 4D5scFv-mCherry-PE(40)


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Development of agents for theranostics implies combining the targeting module, the effector module, and the detection module within the same complex or recombinant protein. We have constructed, isolated, and characterized the 4D5scFv-mCherry-PE(40) protein, which exhibits fluorescent properties and specifically binds to cancer cells expressing the HER2 receptor and reduces their viability. The ability of the obtained targeted antitumor agent 4D5scFv-mCherry-PE(40) to selectively stain the HER2-positive cells and its highly selective cytotoxicity against these cells make the obtained targeted recombinant protein 4D5scFv-mCherry-PE(40) a promising theranostic agent for the diagnostics and therapy of HER2-positive human tumors.

作者简介

O. Shilova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

编辑信件的主要联系方式.
Email: olga.shilova.n@gmail.com
俄罗斯联邦, Moscow, 117997

E. Souslova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: olga.shilova.n@gmail.com
俄罗斯联邦, Moscow, 117997

A. Pilunov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: olga.shilova.n@gmail.com
俄罗斯联邦, Moscow, 117997

S. Deyev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry; Nizhny Novgorod State University

Email: olga.shilova.n@gmail.com
俄罗斯联邦, Moscow, 117997; Nizhny Novgorod, 603600

R. Petrov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: olga.shilova.n@gmail.com
俄罗斯联邦, Moscow, 117997

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2016